ISAL 2019 | Prevention, detection and treatment of AML relapse after allo-SCT

Thomas Schröder

Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses the prevention, detection and treatment of the acute myeloid leukemia (AML) relapse after allogeneic stem cell transplantation. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

Share this video